Pradeep Rai, MD
Surgery · Denver, CONPI 1184863631
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (48.6%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Indivior Inc. accounts for 88.2% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $6,095 and has fallen 93.0% since, to $427 in 2025.
Across 32 payments — averaging $273.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Indivior Inc.$8K
- Organogenesis Inc.$445
- Integra Lifesciences Corporation$409
- USWM, LLC$42
- Piramal Critical Care$38
- AbbVie$32
- plus $67 from 3 others
What the payments were for
- Consulting fees$1,62019%
- Speaking & faculty fees$4,25049%
- Travel & lodging$1,51017%
- Food & beverage$96811%
- Other$3924%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Indivior Inc. | 15 | $7,708 |
| Organogenesis Inc. | 7 | $445 |
| Integra Lifesciences Corporation | 3 | $409 |
| USWM, LLC | 2 | $42 |
| Piramal Critical Care | 1 | $38 |
| AbbVie | 1 | $32 |
| Alkermes, Inc. | 1 | $26 |
| Orexo US, Inc. | 1 | $23 |
| Urgo Medical North America, LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SUBLOCADE$7,503
- MICROMATRIX$392
- PuraPly$217
How this compares
$8,740 in reported general payments places this provider in the 75th percentile of 469 surgery providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 85 | $23,576 |
| FarxigaDapagliflozin Propanediol | 22 | $6,253 |
| MyrbetriqMirabegron | 23 | $5,213 |
| Metoprolol Succinate | 30 | $436 |
| Potassium Chloride | 26 | $308 |
| Diltiazem 24hr ErDiltiazem Hcl | 22 | $276 |
| Lisinopril | 19 | $212 |
| Furosemide | 32 | $201 |
| Sertraline Hcl | 16 | $201 |
| Olanzapine | 14 | $158 |
| Tamsulosin Hcl | 17 | $156 |
| Amlodipine Besylate | 16 | $153 |
| Levothyroxine Sodium | 14 | $129 |
| Atorvastatin Calcium | 14 | $114 |
| Spironolactone | 11 | $110 |
Paid to pharmacies, not to this prescriber.
Other surgery in Denver
- Anthony CanfieldDenver$854K
- Michael SnyderDenver$123K
- Edward JonesDenver$70K
- Drew AlbrightDenver$46K
- Jeffrey CrossDenver$40K
- John WeaverDenver$39K
- Megan LooDenver$36K
- Scott GolembeskiDenver$30K
- David BaerDenver$26K
- Kimberly VanderveenDenver$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.